Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer

Oncology Letters

Volumn 4, Issue 6, 2012, Pages 1309-1314

  Xue, Sheng Liu ^a   Su, Hua Fang ^a   Hu, Xiao Qu ^a   Deng, Xia ^a   Hu, Mei Long ^a   Xie, Cong Ying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant chemotherapy; Combined therapy; Intraperitoneal chemotherapy; Locally advanced gastric cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HIGH RISK PATIENT; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PERITONEUM METASTASIS; SEROSA; STOMACH CANCER; SURVIVAL RATE; TREATMENT FAILURE;

EID: 84867256432     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.914     Document Type: Article

References (27)

1. Zhao P, Dai M, Chen W and Li N: Cancer trends in China. Jpn J Clin Oncol 40: 281-285, 2010.
2. Wu CW, Lo SS, Shen KH, et al: Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg 27: 153-158, 2003.
3. Sugarbaker PH, Yu W and Yonemura Y: Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21: 233-248, 2003.
4. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730, 2001.
5. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20, 2006.
6. Sasako M, Sakuramoto S, Katai H, et al: Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29: 4387-4393, 2011.
7. Yang XJ, Huang CQ, Suo T, et al: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18: 1575-1581, 2011.
8. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, et al: Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303: 1729-1737, 2010.
9. Sun P, Xiang JB and Chen ZY: Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 96: 26-33, 2009.
10. Liu TS, Wang Y, Chen SY and Sun YH: An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol 34: 1208-1216, 2008.
11. Xu DZ, Zhan YQ, Sun XW, Cao SM and Geng QR: Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 10: 2727-2730, 2004.
12. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G and Morris DL: A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14: 2702-2713, 2007.
13. Sugarbaker PH: Adjuvant intraperitoneal chemotherapy for advanced primary gastric cancer. Scand J Surg 95: 270-273, 2006.
14. Armstrong DK, Bundy B, Wenzel L, et al: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354: 34-43, 2006.
15. American Joint Committe on Cancer (AJCC): Cancer staging handbook: TNM classification of malignant tumours. 6th edition. Springer, New York, pp99-106, 2002.
16. Sano T and Aiko T: New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 14: 97-100, 2011.
17. Matharu G, Tucker O and Alderson D: Systematic review of intraperitoneal chemotherapy for gastric cancer. Br J Surg 98: 1225-1235, 2011.
18. Scheithauer W, Kornek GV, Marczell A, et al: Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer 77: 1349-1354, 1998.
19. Atiq OT, Kelsen DP, Shiu MH, et al: Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 11: 425-433, 1993.
20. Zuo Y, Xu M, Shen D, Lu WD and Lu JF: Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients. Zhonghua Zhong Liu Za Zhi 26: 247-249, 2004.
21. Shi C, Yang B, Chen Q, Yang J and Fan N: Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer. Oncology 80: 289-295, 2011.
22. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M and Karpeh MS: Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240: 808-816, 2004.
23. Schilsky RL, Choi KE, Grayhack J, Grimmer D, Guarnieri C and Fullem L: Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer. J Clin Oncol 8: 2054-2061, 1990.
24. Yu W, Whang I, Averbach A, Chang D and Sugarbaker PH: Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. Am Surg 64: 1104-1108, 1998.
25. Rosen HR, Jatzko G, Repse S, et al: Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol 16: 2733-2738, 1998.
26. De Vita F, Vecchione L, Galizia G, et al: Perspectives in adjuvant therapy of gastric cancer. Oncology 77: 38-42, 2009.
27. Bittoni A, Maccaroni E, Scartozzi M, Berardi R and Cascinu S: Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives. Eur Rev Med Pharmacol Sci 14: 309-314, 2010.